
The vaccine uses a single Ebola virus protein to stimulate an immune response but cannot cause someone who is given it to become infected, scientists say. The trial will start as soon as ethical approval is granted, experts at the Wellcome Trust say. via Pocket http://ift.tt/1nHuP62
No comments:
Post a Comment